Polish biotechnology company Mabion S.A. signs an agreement with Novavax to begin commercial-scale production trials for Novavax's future vaccine. (Bloomberg) COVID-19 pandemic in PolandCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save